People · Operator

John Reynders

Named in public records as an officer, director or promoter · active 2025–2025 · Other Health Care

1
Companies
1
Filings
$5.7M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Certara, Inc.Other Health CareSeries A$5.7M$21.0M2025
Operator network

John Reynders at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Stephen McLean · 4 companies · 1 sharedStephen McLeanMatthew Walsh · 3 companies · 1 sharedMatthew WalshCynthia Collins · 2 companies · 1 sharedCynthia CollinsEran Broshy · 2 companies · 1 sharedEran BroshyAdrian McKemey · 1 companies · 1 sharedAdrian McKemeyDaniel Corcoran · 1 companies · 1 sharedDaniel CorcoranDavid Spaight · 1 companies · 1 sharedDavid SpaightJames Cashman · 1 companies · 1 sharedJames CashmanJohn Gallagher III · 1 companies · 1 sharedJohn Gallagher IIILeif Pedersen · 1 companies · 1 sharedLeif PedersenNancy Killefer · 1 companies · 1 sharedNancy KilleferRobert Aspbury · 1 companies · 1 sharedRobert AspburyRona Anhalt · 1 companies · 1 sharedRona AnhaltRosemary Crane · 1 companies · 1 sharedRosemary CraneWilliam Feehery · 1 companies · 1 sharedWilliam FeeheryCertara, Inc. · $5.7M raisedCertara, Inc.John ReyndersJR
John Reynders Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John Reynders on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Stephen McLean14
Matthew Walsh13
Eran Broshy12
Cynthia Collins12
Daniel Corcoran11
Robert Aspbury11
Leif Pedersen11
William Feehery11
David Spaight11
Rosemary Crane11
James Cashman11
Nancy Killefer11
John Gallagher III11
Adrian McKemey11
Rona Anhalt11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.